---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-031587"
form_type: "8-K"
ticker: "PHGE"
cik: "0001739174"
company_name: "BiomX Inc."
filed_at: "2026-03-19T23:59:59+00:00"
generated_at: "2026-05-15T09:39:09.231262+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BiomX amends warrants to 1-year term at $1 exercise; outlines strategic reset

## Summary
- Warrant term shortened to expire Dec 31, 2026; exercise price reduced from $2.00 to $1.00 per share.
- CEO letter cites warrant overhang reduction and plans to reposition toward defense-related technologies.
- Company finalizing closure of Maryland facility to cut overhead and strengthen financial foundation.
- Active engagement with investment banks and institutional investors for future capital access.
- No change in number of shares issuable upon exercise; cashless exercise VWAP formula revised.

## SEC filing metadata
- accession: 0001213900-26-031587
- form_type: 8-K
- ticker: PHGE
- cik: 0001739174
- company_name: BiomX Inc.
- filed_at: 2026-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739174/000121390026031587/0001213900-26-031587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739174/000121390026031587/ea0282582-8k_biomx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-031587
- JSON: https://secwatch.observer/filing/0001213900-26-031587.json
- Plain text: https://secwatch.observer/filing/0001213900-26-031587.txt

## Source-grounded claims
- claim_id: c91574d18fe7ecb715e91d2d3a7a206d22e5c98b
  claim: BiomX Inc. amended Warrant Amendment with the Investor (effective 2026-03-13).
  evidence_excerpt: On March 13, 2026, the Company and the Investor entered into an amendment to the Warrant (the “Warrant Amendment”), pursuant to which, the Investor and the Company agreed to (i) amend the term of the Warrant, such that the Warrant will expire on December 31, 2026, (ii) reduce the exercise price of the Warrant from $2.00 to $1.00 per share, and (iii) revise the method of determining the number of shares of Common Stock issuable upon a cashless exercise of the Warrant such that the number of shares of Common Stock issuable upon cashless exercise will be determined by reference, where applicable, to the lowest VWAP on the five (5) trading days immediately preceding the date on which the notice of exercise is submitted to the Company, rather than the VWAP on the day immediately preceding the date on which the notice of exercise is submitted.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739174/000121390026031587/0001213900-26-031587-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.